![logo](/logos/FEMY.webp)
Femasys Inc.
NASDAQ:FEMY
1.07 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Femasys Inc. |
Symbool | FEMY |
Munteenheid | USD |
Prijs | 1.07 |
Beurswaarde | 23,789,096 |
Dividendpercentage | 0% |
52-weken bereik | 0.248 - 4.75 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Ms. Kathy Lee-Sepsick |
Website | https://www.femasys.com |
An error occurred while fetching data.
Over Femasys Inc.
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)